{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:57:25Z","timestamp":1792785445917,"version":"4.5.0"},"reference-count":97,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["555525825"],"award-info":[{"award-number":["555525825"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022766","name":"Fundaci\u00f3n contra la Hipertensi\u00f3n Pulmonar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022766","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agencia Estatal de Investigaci\u00f3n","award":["PID2024-159407OB-I00"],"award-info":[{"award-number":["PID2024-159407OB-I00"]}],"id":[{"id":"https:\/\/ror.org\/003x0zc53","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["JR23\/00071"],"award-info":[{"award-number":["JR23\/00071"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.1080\/14728222.2026.2709796","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:28:50Z","timestamp":1784816930000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Breakthroughs in our molecular understanding of therapeutic targets for pulmonary hypertension"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3268-0752","authenticated-orcid":false,"given":"Gerrit","family":"Bredeck","sequence":"first","affiliation":[{"name":"CSIC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4037","authenticated-orcid":false,"given":"Alejandro","family":"Cruz-Utrilla","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria 12 de Octubre (i+12)","place":["Madrid, Spain"]},{"name":"European Reference Network for Rare Respiratory Diseases (ERN-Lung)","place":["Frankfurt-Am-Main, Germany"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9340-882X","authenticated-orcid":false,"given":"Eduardo","family":"Oliver","sequence":"additional","affiliation":[{"name":"CSIC","place":["Madrid, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV)","place":["Madrid, Spain"]},{"name":"Spanish National Center for Cardiovascular Research (CNIC)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007414"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306142"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.068"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01830-2024"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01064-4"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050010"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024277"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213558"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202401-0089PP"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.05.004"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3877"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24838"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14620"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/79226"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020617"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01435-2024"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01483-2024"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2024.11.037"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.02.024"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000765"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00072-9"},{"key":"e_1_3_4_27_1","unstructured":"A Phase 3 randomized Double-blind placebo-controlled study to evaluate the efficacy and safety of oral inhalation of seralutinib for the treatment of pulmonary arterial hypertension (PAH) [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05934526"},{"key":"e_1_3_4_28_1","article-title":"Gossamer Bio announces topline results from the Phase 3 PROSERA study evaluating seralutinib in pulmonary arterial","author":"Gossamer Bio","year":"2026","unstructured":"Gossamer Bio. Gossamer Bio announces topline results from the Phase 3 PROSERA study evaluating seralutinib in pulmonary arterial. Hypertension. 2026 [cited 2026 09\/06]. Available from: https:\/\/ir.gossamerbio.com\/node\/9696\/pdf","journal-title":"Hypertension"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01905-3"},{"key":"e_1_3_4_30_1","unstructured":"A Phase 2 multicentre open-label trial to evaluate APL-9796 in adult participants with pulmonary hypertension (ViTAL-PH) [Internet]. 2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06846554"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.182014"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01761-2019"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2274OC"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.08.011"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70110"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045893218757596"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02463-2020"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000001198"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.048371"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105197"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq583"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23781"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217735820"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.933762"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1631LE"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1331PP"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0442OC"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3481OC"},{"key":"e_1_3_4_49_1","unstructured":"A randomized Double-blind placebo-controlled Phase II multicenter trial of a monoclonal antibody to CD20 (Rituximab) for the treatment of systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) [Internet]. 2010. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01086540"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311737"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.038"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.263848"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031655"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-024-01041-5"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2025.2507034"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev136"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018349"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1118796"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1562OC"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao4583"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70050-6"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-2494"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00971-w"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.05.042"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1086\/690236"},{"key":"e_1_3_4_66_1","unstructured":"Clinical trial of 2-HOBA in pulmonary arterial hypertension [Internet]. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06176118"},{"key":"e_1_3_4_67_1","unstructured":"A dose-ranging study of the efficacy and safety of bardoxolone methyl in patients with pulmonary hypertension [Internet]. 2014. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02036970"},{"key":"e_1_3_4_68_1","unstructured":"A study of the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension [Internet]. 2016. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02657356"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0357OC"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01205-2024"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804710"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602253"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.05.025"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30686-7"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706135"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18742-9"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-155846"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.062"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00425-9"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01734-2025"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.320121"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2023-0308OC"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101721-032910"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.06.004"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2780"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0567-0"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.70232"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.3808"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.64898\/2026.07.14.738203"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2745"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4974"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0030-2025"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.058794"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01324-7"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313906"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.321780"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2018.7705"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01233"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2017.02.020"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2026.2709796","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14728222.2026.2709796","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2026.2709796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:14:20Z","timestamp":1790082860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2026.2709796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"alternative-id":["10.1080\/14728222.2026.2709796"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2026.2709796","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}